Juno Lighting, Inc. JUNO
86.96 0.00 (+0.00%)
At closeJun 28, 2019, 6:07 PM EDT
86.96 Day range 86.96
85.47 52-week range 85.77
- EPS (ttm)
- -4.16
- P/E ratio
- -20.89
- Avg volume
- 2.68M
- Open
- 86.96
- Previous close
- 86.96
- Day's range
- 86.96 – 86.96
- 52-week range
- 85.47 – 85.77
- Earnings date
- Mar 7, 2018
No chart data for this range yet.
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Mar 7, 2018
Expected Mar 7, 2018. Consensus EPS estimate 0.00.
Financials — quick view
JUNO Revenue — quarterly 26.46M
JUNO Net income — quarterly -136.04M
JUNO EPS — quarterly -1.22
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 7, 2018 | Dec 1, 2017 | -1.15 | — | — | — |
| Nov 1, 2017 | Sep 1, 2017 | -0.82 | — | — | — |
| Aug 3, 2017 | Jun 1, 2017 | -0.73 | — | — | — |
| May 4, 2017 | Mar 1, 2017 | -0.65 | — | — | — |
| Mar 1, 2017 | Dec 1, 2016 | -0.62 | — | — | — |
| Nov 9, 2016 | Sep 1, 2016 | -0.65 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 23, 2018 | Standpoint Research | down | Buy | Hold |
| Jan 23, 2018 | Barclays | down | Overweight | Equal-Weight |
| Jan 22, 2018 | Maxim Group | down | Buy | Hold |
| Jan 22, 2018 | Leerink Swann | down | Outperform | Market Perform |
| Jan 22, 2018 | SunTrust Robinson Humphrey | down | Buy | Hold |
| Jan 17, 2018 | Citigroup | down | Buy | Neutral |
News
Seren Juno and Ribbon Achieve 20Tbps Transmission on 10,000 km JUNO Trans-Pacific Cable 
NTT DATA-led JUNO Submarine Cable Plans to Deploy Ciena's WaveLogic 6 to Boost Network Capacity 
Britain's Royal Mint launches coin for 80th anniversary of D-Day landings 
Juno Therapeutics to Report Third Quarter 2017 Financial Results on
Wednesday, November 1 
Juno Therapeutics to Report Second Quarter 2017 Financial Results on
Thursday, August 3 
Juno Therapeutics to Report First Quarter 2017 Financial Results on
Thursday, May 4 
Freeport-McMoRan, Juno Therapeutics, Square And European Banks: Fast Money Picks For April 26 
Juno Therapeutics to Report Full Year and Fourth Quarter 2016
Financial Results on Wednesday, March 1 
Juno Therapeutics Places JCAR015 Phase II ROCKET Trial on Clinical
Hold 
Juno Therapeutics to Report Third Quarter 2016 Financial Results on
Wednesday, November 9
Your note
Sign in to keep a note on JUNO — it syncs with the Stock Master app.